查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1483116

侧流分析组件市场评估：依组件类型、依应用类型、依技术类型、依最终用户、依地区、机会、预测，2017-2031 年

Lateral Flow Assay Components Market Assessment, By Component Type, By Application Type, By Technique Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 220 Pages | 商品交期: 3-5个工作天内

价格
根据预测，全球侧流分析组件市场规模将从 2023 年的 103.5 亿美元成长到 2031 年的 159.5 亿美元，2024-2031 年预测期间复合年增长率为 5.55%。近年来，市场经历了显着成长，预计未来将保持强劲的扩张速度。基于侧向流动的测定 (LFA) 用于定性和定量分析，其用途正在扩展到各种应用。 LFA 是使用将多个部件放置在一块塑胶上的条带进行的。这些零件包括硝酸纤维素膜、吸附垫、结合垫和加样垫。 LFA 是一种结合了多种基于 LFA 格式的色谱法和生物辨识探针的优点的技术。

由于传染病流行、技术进步和公众对临床检测的认识等因素，全球侧流检测组件市场预计将扩大。基于 LFA 的试纸条在市场上很容易买到，因为它们可用于各种类型的诊断测试。基于 LFA 的试纸条可用于各种类型的诊断测试。市场公司正在推出和开发用于各种测试的试纸，使这些试纸更可靠且需求量更大。基于侧向流动的测试因其准确性和速度而越来越受欢迎。国际品牌正在合作并投资这些检测方法的开发，使市场的投资利润丰厚。

本报告调查了全球侧流分析组件市场，并提供了市场概述，以及依组件类型、应用类型、技术类型、最终用户、地区和进入市场的公司划分的趋势。

目录

第一章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第 4 章 2017-2031 年全球侧流分析组件市场展望

  • 市场规模与预测
  • 依组件类型
  • 依应用程式类型
  • 依技术型
  • 依最终用户
  • 依地区
  • 各公司的市占率 (%)，2023 年

第 5 章全球侧向层析侦测组件市场展望：依地区划分，2017-2031 年

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东/非洲

第 6 章市场地图，2023 年

第七章宏观环境与产业结构

  • 需求与供给分析
  • 汇入/汇出分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市场动态

第 9 章监理架构与创新

第十章主要参会企业状况

第11章价格分析

第 12 章案例研究

第 13 章主要进入者展望

  • Danaher Corporation
  • PerkinElmer Inc.
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • Qiagen N.V.
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.

第 14 章策略建议

第十五章查询及免责声明

Product Code: MX11364

Global lateral flow assay components market is projected to witness a CAGR of 5.55% during the forecast period 2024-2031, growing from USD 10.35 billion in 2023 to USD 15.95 billion in 2031. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years. Lateral flow-based assays (LFA) are used for qualitative and quantitative analysis, and their use is expanding across various applications. It is carried out using a strip which is made of several parts placed on a plastic piece. These parts include the nitrocellulose membrane, adsorption pad, conjugate pad, and sample application pad. LFA is a technique that combines the benefits of chromatography and biorecognition probes in the form of various LFA-based formats.

The global lateral flow assay components market is expected to expand due to factors such as increasing prevalence of infectious diseases, technological advancements, and the awareness among general population about clinical testing. LFA-based strips are easily available in the market for different types of diagnostic tests. The comfort that it offers at a very minimal price is one of the reasons behind its success. As market players are launching and developing different strips for a variety of tests, reliability on these strips is increasing, which is making them a product that is high in demand. The accuracy and swiftness of lateral flow-based assays' tests have made them popular. International brands are investing in the development of these assays in partnerships, making its market profitable to invest in. For example, Upfront Diagnostics, a Cambridge, UK-based company, conducts clinical research of a lateral flow test. This test will enable paramedics to screen patients who may have suffered a stroke for big artery occlusions, allowing them to triage patients and provide the best care possible quickly. LVOne's test results are derived from a finger prick, which uses two indicators and has a turnaround time of roughly 15 minutes, and paramedics can visually analyze the results.

Rising Prevalence of Infectious Diseases

The aging population is more susceptible to chronic illnesses like cystic fibrosis, cardiovascular diseases, hepatitis, and cancer because of physiological changes, metabolic issues, and weak immune systems. Changes in lifestyle, such as a sedentary lifestyle and increasing consumption of cigarettes and alcohol, will accelerate the spread of disease in the forecast period. It is anticipated that the rising incidences of infectious diseases like HIV and malaria, etc. will lead to increasing demand for lateral flow assay components. Infectious diseases are a major health concern worldwide, and efficient disease treatment depends on quick and precise diagnostic testing. LFAs are frequently employed in the detection of infectious illnesses, including malaria, HIV, and tuberculosis. Diagnostic testing carried out at or close to the location of patient care is referred to as "point-of-care" testing. Since point-of-care testing can yield results in a matter of minutes, requires no sample preparation, and is easy to use, LFAs are perfect for point-of-care testing. The need for self-testing at home has increased after the COVID-19 pandemic.

LFAs are a good choice for self-testing at home as they are simple provide fast results. The development of lateral flow tests that may be utilized for patient-specific diagnosis and therapy is being driven by the increasing need for personalized medicine. According to a report published by National Institutes of Health (NIH) in 2023, ever since the COVID-19 pandemic, the number of cases recorded increased by 259.4% (2,227,613 cases in 2021 and 8,006,631 cases in 2022), primarily due to five diseases: mumps (2656% rise), malaria (990% rise), polio (2100% rise), influenza (354% rise), and diphtheria (419% rise).

Clinical Testing Segment Drives Market Growth

Since clinical testing is important for diagnosing and detecting illnesses, it is expected to account for the highest market share in the lateral flow assay market. The need for these tests is anticipated to develop in tandem with the prevalence of infectious diseases and other illnesses, propelling the segment's expansion. The segment's demand has surged because of more self-test devices, including Atomo HIV Self-Test, TRUSTline HIV-Ab/Ag 4th Gen Rapid Test, Dr. Trust HIV Sure, and others, being approved as safe and accurate. Patients benefit from these self-test tools and kits in terms of assurance, quick diagnosis, increased convenience, and simplicity of use, all of which are projected to drive market growth. In addition, the COVID-19 pandemic has significantly boosted clinical testing launches and research, which has supported the segment's growth. EDX Medical Group Plc. announced in 2023 that scientists from Oxford and Cambridge were developing a new generation of rapid healthcare tests, known as 'point-of-care' tests. They are being used to detect and characterize a plethora of diseases within a very short time. These tests use combined multiple assays and a smartphone which can support real-time clinical decision-making and improve outcomes for patients.

Increasing Demand for Home-Based Testing Method

The market is expected to grow at a faster rate during the forecast period due to the rising demand for home-based testing kits for the detection of chronic diseases, pregnancy, fertility, coagulation, urine chemistry, and other tests. Additionally, the growing demand for point-of-care testing may further enhance the demand for lateral flow assay, and the device's usage is increasing rapidly. Major players in the field are prioritizing advanced point-of-care devices based on lateral flow assays for uses like HCG levels and ovulation-based pregnancy tests, diagnosing infectious diseases and medication, and measuring protein markers in the boost, which is anticipated to increase demand for lateral flow assays over time. Innovation in lateral flow assays is being fuelled by research and development, which is leading to the production of new and advanced assays for diagnostic testing. Lateral flow tests' sensitivity, specificity, and accuracy are being improved by technological developments, which increase their efficacy and dependability as diagnostic tools. In 2024, Maxim Bio received funds from NIH, totalling up to USD 4.4 million, in phase 2 of developing the FiarFly platform. It supports various tests at home as well as can prepare for clinical trials targeting influenza season. This tool is a flexible, low-cost and compact solution designed to bring diagnostic testing closer to the patient, providing lab-comparable performance at home at a very affordable cost.

North America Dominates the Global Lateral Flow Assay Components Market

Rising chronic illnesses, infectious diseases, changing lifestyles, increasing geriatric population, increasing investment in research and development, and the presence of major players in the region are why North America dominates the global lateral flow assay components market. Furthermore, due to rising rates of HIV/AIDS-related mortality as well as an increase in the prevalence of several chronic and infectious diseases, including tuberculosis and Lyme disease, North America is predicted to lead the global lateral flow assay components market during the forecast period. According to the Centers for Disease Control and Prevention, in 2022, influenza and pneumonia caused 41,917 deaths in the United States. Additionally, it has been noted that several infectious diseases, including meningitis and urinary tract infections, are spreading quickly and require prompt diagnosis. Additionally, the region's market is expected to be stimulated by the increasing number of diagnostic centres, growing awareness among public about diagnostic tests and technological advancements, all of which will contribute to the region's exceptional revenue share of the global market during the projection period.

In 2023, Inflammatix, Inc. announced that they were developing a blood test that would take 30 minutes to complete and could benefit emergency room doctors in the triage of patients who may have sepsis or other acute infections. The test can assist medical professionals in distinguishing between viral and bacterial infections and in creating risk scores that indicate the possibility that the patient may experience a serious illness in the next few days that will necessitate treatments like renal replacement therapy or mechanical breathing.

Future Market Scenario (2024-2031F)

The rising prevalence of various infectious diseases in the population is one of the biggest reasons why we can expect the lateral flow assay components market to grow in the forecast period. Viral infections are shown to be the most widespread among all and are most easily and commonly transmissible, which raises a concern and hence requires quick diagnosis. Technology and diagnostic approaches that are effective and cost-efficient are being introduced by players in this industry who are growing at an unmatched pace. The government is taking initiatives, bringing in new policies, and raising funds to improve the shape of healthcare around the globe. The successful creation of Optimer binders to enable a lateral flow test for the early diagnosis of Alzheimer's disease was announced in 2023 by Aptamer Group plc, the manufacturers of the new Optimer binders, and Neuro-Bio, an Oxford-based biotechnology business with a therapeutic emphasis on neurodegenerative disease.

Key Players Landscape and Outlook

Several companies, such as Danaher Corporation, PerkinElmer Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Becton, Dickinson and Company, Qiagen N.V., Abbott Laboratories, Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific Inc., etc., are expanding their businesses by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed LFA strips, to help researchers and increase their market presence. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few ways companies aim to increase their market shares.

The Tools for Life Sciences team at the Swiss Center for Electronics and Microtechnology (CSEM) is developing a state-of-the-art point-of-care solution for preeclampsia diagnostics in collaboration with MOMM Diagnostics. This innovative multiplexed sensing gadget simultaneously detects two important biomarkers linked to this common disease.

Bioengineers at Rice University announced that they successfully proposed a low-cost, point-of-care DNA test for HPV infections. This development may improve access to cervical cancer screening in low- and middle-income nations, where the illness claims the lives of over 300,000 women annually.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Lateral Flow Assay Components Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2.By Volume
  • 4.2.By Component Type
    • 4.2.1.Membranes
    • 4.2.2.Pads
    • 4.2.3.Others
  • 4.3.By Application Type
    • 4.3.1.Clinical Testing
      • 4.3.1.1.Infectious Disease Testing
      • 4.3.1.2.Pregnancy Testing
      • 4.3.1.3.Cardiac Marker Testing
      • 4.3.1.4.Cholesterol Testing
      • 4.3.1.5.Drug-Abuse Testing
      • 4.3.1.6.Others
    • 4.3.2.Veterinary Testing
    • 4.3.3.Food Safety and Environmental Testing
    • 4.3.4.Drug Development and Quality Testing
    • 4.3.5.Others
  • 4.4.By Technique Type
    • 4.4.1.Sandwich Assays
    • 4.4.2.Multiplex-Detection Assays
    • 4.4.3.Competitive Assays
  • 4.5.By End-user
    • 4.5.1.Hospitals
    • 4.5.2.Diagnostic Laboratories
    • 4.5.3.Home-Care Settings
    • 4.5.4.Pharmaceutical and Biotechnology Companies
    • 4.5.5.Academic and Research Institutes
  • 4.6.By Region
    • 4.6.1.North America
    • 4.6.2.Europe
    • 4.6.3.Asia-Pacific
    • 4.6.4.South America
    • 4.6.5.Middle East and Africa
  • 4.7.By Company Market Share (%), 2023

5.Global Lateral Flow Assay Components Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Component Type
      • 5.1.2.1.Membranes
      • 5.1.2.2.Pads
      • 5.1.2.3.Others
    • 5.1.3.By Application Type
      • 5.1.3.1.Clinical Testing
        • 5.1.3.1.1.Infectious Disease Testing
        • 5.1.3.1.2.Pregnancy Testing
        • 5.1.3.1.3.Cardiac Marker Testing
        • 5.1.3.1.4.Cholesterol Testing
        • 5.1.3.1.5.Drug-Abuse Testing
        • 5.1.3.1.6.Others
      • 5.1.3.2.Veterinary Testing
      • 5.1.3.3.Food Safety and Environmental Testing
      • 5.1.3.4.Drug Development and Quality Testing
      • 5.1.3.5.Others
    • 5.1.4.By Technique Type
      • 5.1.4.1.Sandwich Assays
      • 5.1.4.2.Multiplex-Detection Assays
      • 5.1.4.3.Competitive Assays
    • 5.1.5.By End-user
      • 5.1.5.1.Hospitals
      • 5.1.5.2.Diagnostic Laboratories
      • 5.1.5.3.Home-Care Settings
      • 5.1.5.4.Pharmaceutical and Biotechnology Companies
      • 5.1.5.5.Academic and Research Institutes
    • 5.1.6.United States*
      • 5.1.6.1.Market Size & Forecast
        • 5.1.6.1.1.By Value
        • 5.1.6.1.2.By Volume
      • 5.1.6.2.By Component Type
        • 5.1.6.2.1.Membranes
        • 5.1.6.2.2.Pads
        • 5.1.6.2.3.Others
      • 5.1.6.3.By Application Type
        • 5.1.6.3.1.Clinical Testing
          • 5.1.6.3.1.1.Infectious Disease Testing
          • 5.1.6.3.1.2.Pregnancy Testing
          • 5.1.6.3.1.3.Cardiac Marker Testing
          • 5.1.6.3.1.4.Cholesterol Testing
          • 5.1.6.3.1.5.Drug-Abuse Testing
          • 5.1.6.3.1.6.Others
        • 5.1.6.3.2.Veterinary Testing
        • 5.1.6.3.3.Food Safety and Environmental Testing
        • 5.1.6.3.4.Drug Development and Quality Testing
        • 5.1.6.3.5.Others
      • 5.1.6.4.By Technique Type
        • 5.1.6.4.1.Sandwich Assays
        • 5.1.6.4.2.Multiplex-Detection Assays
        • 5.1.6.4.3.Competitive Assays
      • 5.1.6.5.By End-user
        • 5.1.6.5.1.Hospitals
        • 5.1.6.5.2.Diagnostic Laboratories
        • 5.1.6.5.3.Home-Care Settings
        • 5.1.6.5.4.Pharmaceutical and Biotechnology Companies
        • 5.1.6.5.5.Academic and Research Institutes
    • 5.1.7.Canada
    • 5.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East and Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Component Type
  • 6.2.By Application Type
  • 6.3.By Technique Type
  • 6.4.By End-user
  • 6.5.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat From New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Clinical Trials
  • 9.2.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Danaher Corporation
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products and Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus and Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.PerkinElmer Inc.
  • 13.3.Merck KGaA
  • 13.4.F. Hoffmann-La Roche Ltd
  • 13.5.Siemens Healthineers AG
  • 13.6.Becton, Dickinson and Company
  • 13.7.Qiagen N.V.
  • 13.8.Abbott Laboratories
  • 13.9.Bio-Rad Laboratories, Inc.
  • 13.10.Thermo Fisher Scientific Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 3.Global Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 4.Global Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 5.Global Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 6.Global Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Lateral Flow Assay Component Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 9.North America Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 10.North America Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 11.North America Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 12.North America Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 13.North America Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 14.North America Lateral Flow Assay Component Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.United States Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 17.United States Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 18.United States Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 19.United States Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 20.United States Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 21.Canada Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 22.Canada Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 23.Canada Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 24.Canada Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 25.Canada Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 26.Canada Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 27.Mexico Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 28.Mexico Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 29.Mexico Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 30.Mexico Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 31.Mexico Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 32.Mexico Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 34.Europe Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 35.Europe Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 36.Europe Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 37.Europe Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 38.Europe Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 39.Europe Lateral Flow Assay Component Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.Germany Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 42.Germany Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 43.Germany Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 44.Germany Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 45.Germany Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 46.France Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 47.France Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 48.France Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 49.France Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 50.France Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 51.France Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 52.Italy Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Italy Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 54.Italy Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 55.Italy Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 56.Italy Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 57.Italy Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 58.United Kingdom Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 59.United Kingdom Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 60.United Kingdom Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 61.United Kingdom Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 62.United Kingdom Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 63.United Kingdom Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 64.Russia Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.Russia Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 66.Russia Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 67.Russia Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 68.Russia Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 69.Russia Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 70.Netherlands Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 71.Netherlands Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 72.Netherlands Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 73.Netherlands Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 74.Netherlands Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 75.Netherlands Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 76.Spain Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 77.Spain Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 78.Spain Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 79.Spain Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 80.Spain Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 81.Spain Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 82.Turkey Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.Turkey Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 84.Turkey Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 85.Turkey Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 86.Turkey Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 87.Turkey Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 88.Poland Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 89.Poland Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 90.Poland Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 91.Poland Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 92.Poland Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 93.Poland Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 94.South America Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.South America Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 96.South America Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 97.South America Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 98.South America Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 99.South America Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 100.South America Lateral Flow Assay Component Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 102.Brazil Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 103.Brazil Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 104.Brazil Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 105.Brazil Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 106.Brazil Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 107.Argentina Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 108.Argentina Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 109.Argentina Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 110.Argentina Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 111.Argentina Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 112.Argentina Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 113.Asia-Pacific Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 114.Asia-Pacific Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 115.Asia-Pacific Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 116.Asia-Pacific Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 117.Asia-Pacific Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 118.Asia-Pacific Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 119.Asia-Pacific Lateral Flow Assay Component Market Share (%), By Country, 2017-2031F
  • Figure 120.India Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 121.India Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 122.India Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 123.India Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 124.India Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 125.India Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 126.China Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 127.China Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 128.China Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 129.China Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 130.China Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 131.China Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 132.Japan Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 133.Japan Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 134.Japan Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 135.Japan Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 136.Japan Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 137.Japan Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 138.Australia Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 139.Australia Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 140.Australia Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 141.Australia Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 142.Australia Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 143.Australia Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 144.Vietnam Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 145.Vietnam Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 146.Vietnam Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 147.Vietnam Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 148.Vietnam Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 149.Vietnam Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 150.South Korea Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 151.South Korea Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 152.South Korea Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 153.South Korea Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 154.South Korea Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 155.South Korea Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 156.Indonesia Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 157.Indonesia Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 158.Indonesia Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 159.Indonesia Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 160.Indonesia Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 161.Indonesia Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 162.Philippines Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 163.Philippines Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 164.Philippines Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 165.Philippines Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 166.Philippines Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 167.Philippines Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 168.Middle East & Africa Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 169.Middle East & Africa Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 170.Middle East & Africa Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 171.Middle East & Africa Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 172.Middle East & Africa Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 173.Middle East & Africa Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 174.Middle East & Africa Lateral Flow Assay Component Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 176.Saudi Arabia Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 177.Saudi Arabia Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 178.Saudi Arabia Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 179.Saudi Arabia Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 180.Saudi Arabia Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 181.UAE Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 182.UAE Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 183.UAE Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 184.UAE Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 185.UAE Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 186.UAE Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 187.South Africa Lateral Flow Assay Component Market, By Value, In USD Billion, 2017-2031F
  • Figure 188.South Africa Lateral Flow Assay Component Market, By Volume, In Million Units, 2017-2031F
  • Figure 189.South Africa Lateral Flow Assay Component Market Share (%), By Component Type, 2017-2031F
  • Figure 190.South Africa Lateral Flow Assay Component Market Share (%), By Application Type, 2017-2031F
  • Figure 191.South Africa Lateral Flow Assay Component Market Share (%), By Technique Type, 2017-2031F
  • Figure 192.South Africa Lateral Flow Assay Component Market Share (%), By End-user, 2017-2031F
  • Figure 193.By Component Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194.By Application Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195.By Technique Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023